Cargando…
Chemotherapeutic Resistance in Egyptian Acute Myeloid Leukemia Patients
BACKGROUND: Acute Myeloid Leukemia (AML) is a heterogeneous disorder with variable genetic abnormalities and cytogenetic alterations which provide a significant disease prognosis and determine response to therapy. PURPOSE: We aim to investigate the expression of the MDR1 gene in 100 Egyptian AML pat...
Autores principales: | Kassem, Neemat M, Medhat, Nashwa, Kassem, Hebatallah A, El-Desouky3, Mohamed A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852834/ https://www.ncbi.nlm.nih.gov/pubmed/31450916 http://dx.doi.org/10.31557/APJCP.2019.20.8.2421 |
Ejemplares similares
-
The Clinicopathological Impact of Granulocyte-Macrophage Colony-Stimulating Factor Gene Expression and Different Molecular Prognostic Biomarkers in Egyptian Acute Myeloid Leukemia Patients
por: Nagdy, Bassant, et al.
Publicado: (2020) -
Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients
por: Kassem, Neemat M, et al.
Publicado: (2019) -
Role of Granulocyte-Macrophage Colony-Stimulating Factor in Acute
Myeloid Leukemia/Myelodysplastic Syndromes
por: Kassem, Neemat M., et al.
Publicado: (2017) -
The Prognostic Significance of TET2 Single Nucleotide Polymorphism in Egyptian Chronic Myeloid Leukemia
por: Hamed, Nahla A., et al.
Publicado: (2020) -
Nutrigenomics and microbiome shaping the future of personalized medicine: a review article
por: Kassem, Neemat M., et al.
Publicado: (2023)